Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RAPS Annual Meeting In Brief

This article was originally published in The Gray Sheet

Executive Summary

PMA annual report warning: CDRH is "moving toward taking a more stringent review of annual reports," said Thinh Nguyen, CDRH's PMA program operations director, Oct. 19 at the Regulatory Affairs Professional Society annual meeting in Baltimore. The reports, which PMA holders must submit each year to FDA, include information on changes the manufacturer has made to the device as well as new clinical data that has come to light. "I would strongly recommend that you put additional time and effort into developing the best annual report possible before submitting them to the FDA," Nguyen said. He indicated that FDA has stepped up its issuance of deficiency letters to firms concerning annual reports....PMA guidances: FDA is expected to issue guidance documents on annual reports, PMA supplements and real-time application review by early 2006, according to Nguyen...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel